Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nadeno Nanoscience AS
AS
Active
Org 929594622
Professor Brochs Gate 16, 7030
Trondheim
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 3 years old
6 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Nadeno Nanoscience AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AE
Annbjørg Eide Falck
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
CJ
Cristianne Johanna Ferdinand Rijcken
Board of Directors
Board of Directors
2024
OJ
Ole Jesper Dahlberg
Chairman
Chairman
2023
JH
Jonas Hallén
Board of Directors
Board of Directors
2023
JS
Jostein Steensnæs Bjøndal
Board of Directors
Board of Directors
2026
JT
Jan Trygve Håbrekke
Board of Directors
Board of Directors
2024
Former (3)
LL
Lars Lund-Roland
Chairman
Chairman
2022 – 2023
EG
Eli Grong Aursand
Board of Directors
Board of Directors
2023 – 2026
RO
Reidar Olaf Stokke
Shareholders
As of last annual report
Sintef Venture V As — 30.34%
Investitude As — 10.51%
Ystvika Holding As — 8.9%
Devico Invest As — 8.36%
Yrr Holding As — 6.75%
Falcka Holding As — 6.48%
Sondo Fund 1 As — 4.9%
Farvatn Venture As — 3.84%
Esmar As — 3.73%
Helift As — 2.36%
Calypso Invest As — 2.16%
Eidco As — 1.59%
Nadeno Nanoscience As — 1.55%
3c Utvikling As — 1.39%
Turtle Invest As — 1.2%
Angen Eiendom As — 1.08%
Harmonium Invest As — 1.08%
Petors As — 1.08%
97%
Shareholder
Type
Ownership
Votes
Since
Sintef Venture V As
Company
30.34%
30.34%
2025
Investitude As
Company
10.51%
10.51%
2025
Ystvika Holding As
Company
8.9%
8.9%
2025
Devico Invest As
Company
8.36%
8.36%
2025
Yrr Holding As
Company
6.75%
6.75%
2025
Falcka Holding As
Company
6.48%
6.48%
2025
Sondo Fund 1 As
Company
4.9%
4.9%
2025
Farvatn Venture As
Company
3.84%
3.84%
2025
Esmar As
Company
3.73%
3.73%
2025
Helift As
Company
2.36%
2.36%
2025
Calypso Invest As
Company
2.16%
2.16%
2025
Eidco As
Company
1.59%
1.59%
2025
Nadeno Nanoscience As
Company
1.55%
1.55%
2025
3c Utvikling As
Company
1.39%
1.39%
2025
Turtle Invest As
Company
1.2%
1.2%
2025
Angen Eiendom As
Company
1.08%
1.08%
2025
Harmonium Invest As
Company
1.08%
1.08%
2025
Petors As
Company
1.08%
1.08%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Nadeno Nanoscience AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Board of Directors
Board of Directors
2023 – 2024
